A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials
Cecilia Eleuteri(Istituto Superiore di Sanità), Cristina Agresti(Istituto Superiore di Sanità), Caterina Veroni(Istituto Superiore di Sanità), Federica Ferrari(University of Ferrara), Rosella Mechelli, Marco Salvetti, Maria Chiara Buscarinu(Sapienza University of Rome), Giovanni Ristori, Silvia Romano, Stefania Olla(Institute of Genetic and Biomedical Research), Renato Umeton(Harvard University), Girolamo Calò(University of Padua)
Cited by 38
Related Papers
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
|PLoS ONE|2013|511
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390